|
|
|
|
| LEADER |
00708cam a2200277 4500 |
| 001 |
1713.10.f |
| 003 |
arsfunl |
| 008 |
200806 USA 00 0 eng |
| 020 |
# |
# |
|a 0387969446
|
| 040 |
|
|
|a HAG
|
| 080 |
# |
# |
|a 615.778
|
| 100 |
0 |
# |
|a Campbell, William C.
|
| 245 |
0 |
0 |
|a Ivermectin and abamectin
|
| 260 |
# |
# |
|a New York
|b Merck
|c 1989
|
| 300 |
# |
# |
|b 363 p., gráf., 24 cm.
|
| 650 |
# |
0 |
|a IVERMECTINA
|
| 650 |
# |
0 |
|a ABAMECTINA
|
| 650 |
# |
0 |
|a QUIMICA
|
| 650 |
# |
0 |
|a BIOSINTESIS
|
| 650 |
# |
0 |
|a ACCION DE LA IVERMECTINA
|
| 650 |
# |
0 |
|a TOXICOLOGIA
|
| 650 |
# |
0 |
|a FARMACOCINETICA
|
| 650 |
# |
0 |
|a METABOLISMO
|
| 650 |
# |
0 |
|a IVERMECTINA EN ANIMALES
|
| 650 |
# |
0 |
|a IVERMECTINA EN HUMANOS
|
| 090 |
|
|
|a 615.778
|b C 22
|d -
|i 1108769
|u 10
|